CM
OM icon

Crestline Management’s Outset Medical OM Stock Holding History

Crestline Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,375
Closed -$3.02M – 310
2021
Q4 		$3.02M Sell
4,375
-437
-9% -$323K 0.23% 93
2021
Q3 		$3.57M Buy
+4,812
New +$3.28M 0.34% 66

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Crestline Management's OM Position: Q1 2022 in Review

Crestline Management sold out of Outset Medical (OM) in Q1 2022, closing a stake of 4,375 shares — an estimated $3.02M sold.

Crestline Management first reported a position in OM in Q3 2021 and held it in 2 quarters. The position peaked at $3.57M in Q3 2021. 152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

  • Crestline Management reported no remaining Outset Medical position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 4,375 Outset Medical shares in Q1 2022, an estimated $3.02M.
  • Crestline Management first reported a position in Outset Medical in Q3 2021 and held it in 2 quarters.
  • Crestline Management's Outset Medical position peaked at $3.57M in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.